BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29860763)

  • 1. [Expression and clinical significance of MIIP and PAK1 in endometrial carcinoma].
    Jiang S; Tian WY; Yan Y; Teng F; Gao JP; Wang YM; Xue FX
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):359-364. PubMed ID: 29860763
    [No Abstract]   [Full Text] [Related]  

  • 2. MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis.
    Wang Y; Hu L; Ji P; Teng F; Tian W; Liu Y; Cogdell D; Liu J; Sood AK; Broaddus R; Xue F; Zhang W
    J Hematol Oncol; 2016 Oct; 9(1):112. PubMed ID: 27760566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation.
    Siu MK; Kong DS; Ngai SY; Chan HY; Jiang L; Wong ES; Liu SS; Chan KK; Ngan HY; Cheung AN
    PLoS One; 2015; 10(7):e0133467. PubMed ID: 26218748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of p21-activated kinase 1 promotes endometrial cancer progression.
    Lu W; Qu JJ; Li BL; Lu C; Yan Q; Wu XM; Chen XY; Wan XP
    Oncol Rep; 2013 Apr; 29(4):1547-55. PubMed ID: 23338047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Significance of Galectin-1 and Galectin-9 Expression in Endometrial Carcinoma.
    Sun XF; Dai SY
    Gynecol Obstet Invest; 2020; 85(1):34-40. PubMed ID: 31487707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIIP expression predicts outcomes of surgically resected esophageal squamous cell carcinomas.
    Wen J; Liu QW; Luo KJ; Ling YH; Xie XY; Yang H; Hu Y; Fu JH
    Tumour Biol; 2016 Aug; 37(8):10141-8. PubMed ID: 26825982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of ER, PR, C-erbB-2 and Ki-67 in Endometrial Carcinoma and their Relationships with the Clinicopathological Features.
    Yu CG; Jiang XY; Li B; Gan L; Huang JF
    Asian Pac J Cancer Prev; 2015; 16(15):6789-94. PubMed ID: 26434913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of P21-activated kinase 1 and cell division control protein 42 homolog correlates with clinicopathological features and prognosis in cervical carcinoma.
    Feng Y; Fang S; Li M
    J Obstet Gynaecol Res; 2016 Jul; 42(7):860-9. PubMed ID: 27060895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations of P21-activated kinase 1 expression to clinicopathological features of gastric carcinoma and patients' prognosis.
    Wang JX; Zhou YN; Zou SJ; Ren TW; Zhang ZY
    Chin J Cancer; 2010 Jul; 29(7):649-54. PubMed ID: 20591216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of cellular FLICE inhibitory protein (cFLIP) in endometrial adenocarcinoma].
    Chen HX; Liu YJ; Li H; Wang ZS
    Ai Zheng; 2004 Mar; 23(3):254-8. PubMed ID: 15025952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and significance of Rac1, Pak1 and Rock1 in gastric carcinoma.
    Wu YJ; Tang Y; Li ZF; Li Z; Zhao Y; Wu ZJ; Su Q
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):e33-9. PubMed ID: 23298303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and potential role of SNF5 in endometrial carcinoma.
    Sun S; Wu Y; Zeng K; Zhao Y
    BMC Womens Health; 2019 Jan; 19(1):16. PubMed ID: 30683081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis.
    Shang P; Meng F; Liu Y; Chen X
    Tumour Biol; 2015 Jun; 36(6):4479-85. PubMed ID: 25934333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expressions and clinical significance of COX-2, VEGF-C, and EFGR in endometrial carcinoma.
    Cai S; Zhang YX; Han K; Ding YQ
    Arch Gynecol Obstet; 2017 Jul; 296(1):93-98. PubMed ID: 28474124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High TRIM44 expression in endometrial carcinoma is associated with a poorer patient outcome.
    Li P; Yin H; Meng F; Liu S; Liu H; Ma R
    Pathol Res Pract; 2018 May; 214(5):727-731. PubMed ID: 29526558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion.
    Marone M; Scambia G; Ferrandina G; Giannitelli C; Benedetti-Panici P; Iacovella S; Leone A; Mancuso S
    Br J Cancer; 1996 Oct; 74(7):1063-8. PubMed ID: 8855975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of ELF5 in endometrial carcinoma tissues and its clinical significance.
    Yang H; Yan H
    Oncol Lett; 2018 Sep; 16(3):3473-3480. PubMed ID: 30127951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMEFF2 is a novel prognosis signature and target for endometrial carcinoma.
    Gao L; Nie X; Zheng M; Li X; Guo Q; Liu J; Liu Q; Hao Y; Lin B
    Life Sci; 2020 Feb; 243():116910. PubMed ID: 31610211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance and the associated signaling pathway of p21-activated kinase 1 (PAK1) in colorectal cancer.
    Pyo JS; Min KW; Oh IH; Lim DH; Son BK
    Pathol Res Pract; 2023 Nov; 251():154820. PubMed ID: 37801909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of bone morphogenetic protein 10 in cases with endometrial carcinoma and its clinical significance.
    Hu Y; Yu L; Xia F; Liang F; Cheng C; Huang Y; Xiao L
    Clin Transl Oncol; 2021 Aug; 23(8):1711-1716. PubMed ID: 33635467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.